Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity.

beta2-Glycoprotein I (beta2GPI) is a phospholipid-binding serum protein with anticoagulant properties. It plays a vital role in the binding of anti-cardiolipin Abs purified from patients with autoimmune disease when assayed in a cardiolipin (CL) ELISA. Based on a three-dimensional model of beta2GPI, electrostatic calculations, and earlier peptide studies, a highly positively charged amino acid sequence, Lys282-Asn-Lys-Glu-Lys-Lys287, located in the fifth domain of beta2GPI, has been predicted to be the phospholipid binding site. We tested this hypothesis by site-directed mutagenesis of residues in the predicted phospholipid binding site and by assessing the mutants for phospholipid binding and anti-beta2GPI activity. A single amino acid change from Lys286 to Glu significantly decreased the binding of beta2GPI to CL. Double and triple mutants 2k (from Lys286, 287 to Glu286, 287), 2ka (from Lys284, 287 to Glu284, 287), and 3k (from Lys284, 286, 287 to Glu284, 286, 287) possessed no binding of Ab to beta2GPI in a CL ELISA, as well as no inhibitory activity on the binding of iodinated native beta2GPI to CL. These results indicate that the residues Lys284, Lys286, and Lys287 in the fifth domain of beta2GPI are critical for its binding to anionic phospholipids and its subsequent capture for binding of anti-beta2GPI Abs.

[1]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[2]  G. Valesini,et al.  Anticardiolipin and Anti-β2-GPI Are Two Distinct Populations of Autoantibodies , 1996, Thrombosis and Haemostasis.

[3]  M. Igarashi,et al.  Expression of anticardiolipin cofactor, human β2‐glycoprotein I, by a recombinant baculovirus/insect cell system , 1993, Clinical and experimental immunology.

[4]  A. Steinkasserer,et al.  Expression of human recombinant β2‐glycoprotein I with anticardiolipin antibody cofactor activity , 1993, FEBS letters.

[5]  H. Kato,et al.  Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains. , 1991, Biochemistry.

[6]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Kostner,et al.  The binding of β2‐glycoprotein‐I to human serum lipoproteins , 2022 .

[8]  P. Bomans,et al.  Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. , 1986, Biochimica et biophysica acta.

[9]  J. Thorell,et al.  Enzymatic iodination of polypeptides with 125I to high specific activity. , 1971, Biochimica et biophysica acta.

[10]  T. Yasuda,et al.  Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface , 1994, The Journal of experimental medicine.

[11]  A. Wilson,et al.  Some ‘antiphospholipid antibodies’ bind to β2‐glycoprotein I in the absence of phospholipid , 1992, British journal of haematology.

[12]  M. Khamashta,et al.  Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. , 1995, Journal of immunology.

[13]  L. Jovanovič,et al.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. , 1985, The New England journal of medicine.

[14]  C. Chesterman,et al.  Purification of antiphospholipid antibodies using a new affinity method. , 1988, Thrombosis research.

[15]  T. Koike,et al.  Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease , 1990, The Lancet.

[16]  Robert B Sim,et al.  Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I. , 1991, The Biochemical journal.

[17]  S. Santoro,et al.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. , 1990, Annals of internal medicine.